[CYCC] QoQ Quarter Result on 31-Dec-2010 [#Q4]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
31-Mar-2011
Financial Year
2010
Quarter
31-Dec-2010 [#Q4]
Profit Trend
QoQ- 16.68%
YoY- 26.86%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
Revenue 164 168 192 138 159 119 271 -28.43%
PBT -3,571 -3,678 -4,779 -3,323 -3,950 -4,163 -5,244 -22.58%
Tax -126 -126 -191 -151 -143 -230 -133 -3.53%
NP -3,445 -3,552 -4,588 -3,172 -3,807 -3,933 -5,111 -23.10%
Tax Rate - - - - - - - -
Total Cost 3,609 3,720 4,780 3,310 3,966 4,052 5,382 -23.36%
Ratio Analysis
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
NP Margin -2,100.61 -2,114.29 -2,389.58 -2,298.55 -2,394.34 -3,305.04 -1,885.98 7.44%
Per Share
30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 CAGR
EPS -107.75 -128.11 -165.51 -115.84 -172.72 -180.70 -270.70 -45.85%
EPS Diluted -107.75 -128.11 -165.51 -114.43 -172.72 -180.70 -270.70 -45.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.